雌马酚抗菌作用的研究现状及前景展望
Research status and prospect of the antibacterial effect of equol
DOI: 10.12677/AMB.2022.114024, PDF,    科研立项经费支持
作者: 孙 奥, 唐 锐, 李文萱:西南医科大学附属中医医院检验科,四川 泸州;西南医科大学基础医学院,四川 泸州;信彩岩:西南医科大学基础医学院,四川 泸州;王 芬:西南医科大学附属中医医院检验科,四川 泸州
关键词: 雌马酚生物学活性真菌细菌抗菌作用Equol biological activity fungi bacteria antibacterial effect
摘要: 雌马酚是由大豆异黄酮在肠道微生物菌群作用下合成的一类雌激素类似物。其对雌激素受体的亲和力高,且具有比大豆异黄酮更高的生物学活性,是目前研究较为广泛的小分子物质之一。雌马酚具有激素样作用、抗氧化、免疫调节等多种生物学作用。本文主要对雌马酚的生物学活性及抗菌作用研究方面进行综述,旨在为雌马酚在抗菌治疗方面提供新的思路。
Abstract: Equol, is a kind of phytoestrogenic compound, which synthesized by soybean isoflavones by intestinal microbiota. It has high affinity for estrogen receptor and higher biological activity than soybean isoflavones, so it is one of the widely studied small molecule substances. Equol has many biological effects, such as hormone like effect, antioxidation, immune regulation, etc. In this paper, the biological activity and antibacterial effect of equol were reviewed, in order to provide new ideas for the antibacterial treatment of equol.
文章引用:孙奥, 唐锐, 李文萱, 信彩岩, 王芬. 雌马酚抗菌作用的研究现状及前景展望[J]. 微生物前沿, 2022, 11(4): 191-195. https://doi.org/10.12677/AMB.2022.114024

参考文献

[1] Shor, D., Sathyapalan, T., Atkin, S.L. and Thatcher, N.J. (2012) Does Equol Production Determine Soy Endocrine Effects? European Journal of Nutrition, 51, 389-398. [Google Scholar] [CrossRef] [PubMed]
[2] Marrian, G.F. and Haslewood, G.A. (1932) Equol, a New Inactive Phenol Isolated from the Ketohydroxyoestrin Fraction of Mares’ Urine. Biochemical Journal, 26, 1227-1232. [Google Scholar] [CrossRef] [PubMed]
[3] Sathyamoorthy, N. and Wang, T.T. (1997) Differential Effects of Dietary Phyto-Oestrogens Daidzein and Equol on Human Breast Cancer MCF-7 Cells. European Journal of Cancer, 33, 2384-2389. [Google Scholar] [CrossRef
[4] 李燕, 蒋守群, 陈伟. 雌马酚的产生、生物学功能及潜在应用[J]. 动物营养学报, 2014, 26(11): 3236-3244.
[5] Fatima, A., Khan, M.S. and Ahmad, M.W. (2020) Therapeutic Potential of Equol: A Comprehensive Review. Current Pharmaceutical Design, 26, 5837-5843. [Google Scholar] [CrossRef] [PubMed]
[6] Gopaul, R., Knaggs, H.E. and Lephart, E.D. (2012) Biochemical Investigation and Gene Analysis of Equol: A Plant and Soy-Derived Isoflavonoid with Antiaging and Antioxidant Properties with Potential Human Skin Applications. Biofactors, 38, 44-52. [Google Scholar] [CrossRef] [PubMed]
[7] Hirvonen, J., Rajalin, A.M., Wohlfahrt, G., Adlercreutz, H., Wähälä, K. and Aarnisalo, P. (2011) Transcriptional Activity of Estrogen-Related Receptor γ (ERRγ) Is Stimulated by the Phytoestrogen Equol. The Journal of Steroid Biochemistry and Molecular Biology, 123, 46-57. [Google Scholar] [CrossRef] [PubMed]
[8] Sekikawa, A., Ihara, M., Lopez, O., et al. (2019) Effect of S-Equol and Soy Isoflavones on Heart and Brain. Current Cardiology Reviews, 15, 114-135. [Google Scholar] [CrossRef
[9] Alfa, H.H. and Arroo, R.R.J. (2019) Over 3 Decades of Research on Dietary Flavonoid Antioxidants and Cancer Prevention: What Have We Achieved? Phytochemistry Reviews, 18, 989-1004. [Google Scholar] [CrossRef
[10] Fang, K., Dong, H., Wang, D., Gong, J., Huang, W. and Lu, F. (2016) Soy Isoflavones and Glucose Metabolism Inmenopausal Women: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Molecular Nutrition & Food Research, 60, 1602-1614. [Google Scholar] [CrossRef] [PubMed]
[11] Arora, A., Nair, M.G. and Strasburg, G.M. (1998) Antioxidant Activities of Isoflavones and Their Biological Metabolites in a Liposomal System. Archives of Biochemistry and Biophysics, 356, 133-141. [Google Scholar] [CrossRef] [PubMed]
[12] Rüfer, C.E. and Kulling, S.E. (2006) Antioxidant Activity of Isoflavones and Their Major Metabolites Using Different in Vitro Assays. Journal of Agricultural and Food Chemistry, 54, 2926-2931. [Google Scholar] [CrossRef] [PubMed]
[13] Chung, J.E., Kim, S.Y., Jo, H.H., et al. (2008) Antioxidant Effects of Equol on Bovine Aortic Endothelial Cells. Biochemical and Biophysical Research Communications, 375, 420-424. [Google Scholar] [CrossRef] [PubMed]
[14] Cheng, C., Wang, X., Weakley, S.M., et al. (2010) The Soybean Isoflavonoid Equol Blocks Ritonavir-Induced Endothelial Dysfunction in Porcine Pulmonary Arteries and Human Pulmonary Artery Endothelial Cells. The Journal of Nutrition, 140, 12-17. [Google Scholar] [CrossRef] [PubMed]
[15] Mayo, B., Vázquez, L. and Flórez, A.B. (2019) Equol: A Bacterial Metabolite from the Daidzein Isoflavone and Its Presumed Beneficial Health Effects. Nutrients, 11, Article No. 2231. [Google Scholar] [CrossRef] [PubMed]
[16] Tanaka, Y., Kimura, S., Ishii, Y. and Tateda, K. (2019) Equol Inhibits Growth and Spore Formation of Clostridioides difficile. Journal of Applied Microbiology, 127, 932-940. [Google Scholar] [CrossRef] [PubMed]
[17] Suay-García, B. and Pérez-Gracia, M.T. (2019) Present and Future of Carbapenem-Resistant Enterobacteriaceae (CRE) Infections. Antibiotics (Basel), 8, Article No. 122. [Google Scholar] [CrossRef] [PubMed]
[18] Sanhueza, L., Melo, R., Montero, R., Maisey, K., Mendoza, L. and Wilkens, M. (2017) Synergistic Interactions between Phenolic Compounds Identified in Grape Pomace Extract with Antibiotics of Different Classes against Staphylococcus aureus and Escherichia coli. PLOS ONE, 12, e0172273. [Google Scholar] [CrossRef] [PubMed]
[19] Hossain, M.A., Park, H.C., Park, S.W., et al. (2020) Synergism of the Combination of Traditional Antibiotics and Novel Phenolic Compounds against Escherichia coli. Pathogens, 9, Article No. 811. [Google Scholar] [CrossRef] [PubMed]
[20] Kim, H.R. and Eom, Y.B. (2021) Synergistic Activity of Equol and Meropenem against Carbapenem-Resistant Escherichia coli. Antibiotics (Basel), 10, Article No. 161. [Google Scholar] [CrossRef] [PubMed]
[21] Al-Hatmi, A.M.S., Mohsin, J., Al-Huraizi, A. and Khamis, F. (2021) COVID-19 Associated Invasive Candidiasis. Journal of Infection, 82, e45-e46. [Google Scholar] [CrossRef] [PubMed]
[22] Govender, N.P., Todd, J., Nel, J., et al. (2021) HIV Infection as Risk Factor for Death among Hospitalized Persons with Candidemia, South Africa, 2012-2017. Emerging Infectious Diseases, 27, 1607-1615. [Google Scholar] [CrossRef] [PubMed]
[23] San-Juan, R., Aguado, J.M., Lumbreras, C., et al. (2011) Universal Prophylaxis with Fluconazole for the Prevention of Early Invasive Fungal Infection in Low-Risk Liver Transplant Recipients. Transplantation, 92, 346-350. [Google Scholar] [CrossRef
[24] Lee, J.A. and Chee, H.Y. (2010) In Vitro Antifungal Activity of Equol against Candida albicans. Mycobiology, 38, 328-330. [Google Scholar] [CrossRef